Contact Us
Phase-Xs | Biologics & Biosimilars | Coherent Market Insights

HPV stands for human papillomavirus, which constitutes a group of more than 150 related viruses. Every HPV virus has a number or a type. HPVs are attracted to only a specific cell type known as squamous epithelial cells and the viruses can live only in these cells. Some of the human papillomavirus can cause non-cancerous tumors while others can lead to cancer, which includes cancer of the cervix, vagina, vulva, anus, penis, and parts of mouth and throat that comprises mostly of the moist skin in the body. These types of HPVs are considered to be mucosal, as they invade in the living cells on mucosal surfaces. Diagnosis and treatment of the abnormal cells developing in the cervix help in the prevention of cervical cancer. The two most common tests employed to check the behavior of cervical cells are HPV and Pap tests.

The Pap test is a simple smear test, which provides an effective screening measure to determine whether the cervical cells are normal or abnormal. HPV testing is performed to screen for human papillomavirus in the cervix that can lead to cervical cancer. A person observed with abnormal cells through Pap test is recommended to opt for HPV testing for further evaluation of cervical cancer.

Market Dynamics

The rising incidence of chronic diseases such as cervical and vaginal cancer are expected to drive growth of HPV testing and Pap test market. According to the National Cervical Cancer Coalition 2017, around 12,000 women are diagnosed with cervical cancer per year in the U.S. Moreover, the American Sexual Health Association (ASHA) suggests that cervical cancer is amongst one of the most preventable types of cancer. These cancers can be prevented through early detection and treatment of abnormal cell changes that occurs in the cervix prior to the development of cervical cancer cells.

Moreover, new product launch in improving the existing accuracy of HPV testing is also expected to drive growth of global HPV testing and Pap test market. For instance, in June 2016, QIAGEN N.V launched the QIAsure Methylation Test, for determining risk of development of cervical cancer.

Technological advancements in field of diagnostics is also anticipated to drive the market for the forecast period. For instance, on January 2019, Nurx, a consumer health and telemedicine company, launched Home HPV Screening test. The new test allows women to conveniently and affordably check their risk for cervical cancer from the comfort of their own home.

However, the inaccuracy of smear based Pap test leading to low reliability is expected to hamper growth of the global HPV and Pap testing market.

Regional Insights

On the basis of region, the global HPV testing and Pap test market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America holds a dominant position in the global HPV testing and Pap test market and is expected to retain its dominance over the forecast period. This attributes to the increasing number of cases of cervical cancer in the U.S. For instance in 2016, according to the Centers for Disease Control and Prevention (CDC), around 12,984 new cases of cervical cancer were reported in the U.S.

Moreover, rising awareness regarding the benefits of early detection of cancer among female population through conduction of various awareness campaigns and government initiatives is fueling growth of the market. For instance, in January 2016, UAB comprehensive care center along with various other non-profit organizations conducted an awareness program that promoted the use of preventive HPV vaccine by explaining the health and precaution benefits achieved from the vaccine to the women in the U.S.

Furthermore, Asia Pacific is expected to witness significant growth in the market over the forecast period, owing to developments in healthcare infrastructure and increasing patient population in developing countries such as India. For instance, according to reports published in the Indian Journal of Medical Research in 2018, cervical carcinoma is one of the most common and dreaded diseases of women, and in India and accounts for approximately 16% of total cervical cancer cases globally.

Competitive Landscape

Key players operating in the global HPV testing and Pap test market include Qiagen N.V., Abbott Laboratories, Becton, Dickinson & Company, Hologic, Inc., Quest Diagnostics, Femasys, Inc., Roche Diagnostics, Arbor Vita Corporation, Onco Health Corporation, Seegene, Inc., and others. Market players are focused towards providing efficient and accurate tests at low prices to sustain their presence in the market. For instance, in April 2019, Hologic, Inc. received European CE Mark for ThinPrep Genesis processor in Europe. ThinPrep Genesis processor is an automated cytology slide and molecular sample system which allows for accurate and reliable results with increased operational efficiency.

Similarly in February 2018, Becton, Dickinson and Company received FDA approval for the BD Onclarity HPV assay, which detects and identifies HPV genotypes that put women at high risk for cervical cancer.

Market Taxonomy

On the basis of test type, the global HPV and Pap Testing Market is segmented into:

  • HPV Test
  • Pap Test

On the basis of application, the global HPV and Pap Testing Market is segmented into:

  • Cervical Cancer
  • Vaginal Cancer

On the basis of end user, the global HPV and Pap Testing Market is segmented into:

  • Hospitals
  • Diagnostic Centers
  • Home Care Settings
  • Others

On the basis of region, the global HPV and Pap Testing Market market is segmented into:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.

Data Triangulation Methodology | Coherent Market Insights

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Market Analysis | Coherent Market Insights

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Subscribe Newsletter

Kindly Subscribe for our latest news & articles.